Cargando…

Chemical carcinogen safety testing: OECD expert group international consensus on the development of an integrated approach for the testing and assessment of chemical non-genotoxic carcinogens

While regulatory requirements for carcinogenicity testing of chemicals vary according to product sector and regulatory jurisdiction, the standard approach starts with a battery of genotoxicity tests (which include mutagenicity assays). If any of the in vivo genotoxicity tests are positive, a lifetim...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacobs, Miriam N., Colacci, Annamaria, Corvi, Raffaella, Vaccari, Monica, Aguila, M. Cecilia, Corvaro, Marco, Delrue, Nathalie, Desaulniers, Daniel, Ertych, Norman, Jacobs, Abigail, Luijten, Mirjam, Madia, Federica, Nishikawa, Akiyoshi, Ogawa, Kumiko, Ohmori, Kiyomi, Paparella, Martin, Sharma, Anoop Kumar, Vasseur, Paule
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395040/
https://www.ncbi.nlm.nih.gov/pubmed/32594184
http://dx.doi.org/10.1007/s00204-020-02784-5
_version_ 1783565323184635904
author Jacobs, Miriam N.
Colacci, Annamaria
Corvi, Raffaella
Vaccari, Monica
Aguila, M. Cecilia
Corvaro, Marco
Delrue, Nathalie
Desaulniers, Daniel
Ertych, Norman
Jacobs, Abigail
Luijten, Mirjam
Madia, Federica
Nishikawa, Akiyoshi
Ogawa, Kumiko
Ohmori, Kiyomi
Paparella, Martin
Sharma, Anoop Kumar
Vasseur, Paule
author_facet Jacobs, Miriam N.
Colacci, Annamaria
Corvi, Raffaella
Vaccari, Monica
Aguila, M. Cecilia
Corvaro, Marco
Delrue, Nathalie
Desaulniers, Daniel
Ertych, Norman
Jacobs, Abigail
Luijten, Mirjam
Madia, Federica
Nishikawa, Akiyoshi
Ogawa, Kumiko
Ohmori, Kiyomi
Paparella, Martin
Sharma, Anoop Kumar
Vasseur, Paule
author_sort Jacobs, Miriam N.
collection PubMed
description While regulatory requirements for carcinogenicity testing of chemicals vary according to product sector and regulatory jurisdiction, the standard approach starts with a battery of genotoxicity tests (which include mutagenicity assays). If any of the in vivo genotoxicity tests are positive, a lifetime rodent cancer bioassay may be requested, but under most chemical regulations (except plant protection, biocides, pharmaceuticals), this is rare. The decision to conduct further testing based on genotoxicity test outcomes creates a regulatory gap for the identification of non-genotoxic carcinogens (NGTxC). With the objective of addressing this gap, in 2016, the Organization of Economic Cooperation and Development (OECD) established an expert group to develop an integrated approach to the testing and assessment (IATA) of NGTxC. Through that work, a definition of NGTxC in a regulatory context was agreed. Using the adverse outcome pathway (AOP) concept, various cancer models were developed, and overarching mechanisms and modes of action were identified. After further refining and structuring with respect to the common hallmarks of cancer and knowing that NGTxC act through a large variety of specific mechanisms, with cell proliferation commonly being a unifying element, it became evident that a panel of tests covering multiple biological traits will be needed to populate the IATA. Consequently, in addition to literature and database investigation, the OECD opened a call for relevant assays in 2018 to receive suggestions. Here, we report on the definition of NGTxC, on the development of the overarching NGTxC IATA, and on the development of ranking parameters to evaluate the assays. Ultimately the intent is to select the best scoring assays for integration in an NGTxC IATA to better identify carcinogens and reduce public health hazards. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00204-020-02784-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7395040
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-73950402020-08-18 Chemical carcinogen safety testing: OECD expert group international consensus on the development of an integrated approach for the testing and assessment of chemical non-genotoxic carcinogens Jacobs, Miriam N. Colacci, Annamaria Corvi, Raffaella Vaccari, Monica Aguila, M. Cecilia Corvaro, Marco Delrue, Nathalie Desaulniers, Daniel Ertych, Norman Jacobs, Abigail Luijten, Mirjam Madia, Federica Nishikawa, Akiyoshi Ogawa, Kumiko Ohmori, Kiyomi Paparella, Martin Sharma, Anoop Kumar Vasseur, Paule Arch Toxicol Meeting Reports While regulatory requirements for carcinogenicity testing of chemicals vary according to product sector and regulatory jurisdiction, the standard approach starts with a battery of genotoxicity tests (which include mutagenicity assays). If any of the in vivo genotoxicity tests are positive, a lifetime rodent cancer bioassay may be requested, but under most chemical regulations (except plant protection, biocides, pharmaceuticals), this is rare. The decision to conduct further testing based on genotoxicity test outcomes creates a regulatory gap for the identification of non-genotoxic carcinogens (NGTxC). With the objective of addressing this gap, in 2016, the Organization of Economic Cooperation and Development (OECD) established an expert group to develop an integrated approach to the testing and assessment (IATA) of NGTxC. Through that work, a definition of NGTxC in a regulatory context was agreed. Using the adverse outcome pathway (AOP) concept, various cancer models were developed, and overarching mechanisms and modes of action were identified. After further refining and structuring with respect to the common hallmarks of cancer and knowing that NGTxC act through a large variety of specific mechanisms, with cell proliferation commonly being a unifying element, it became evident that a panel of tests covering multiple biological traits will be needed to populate the IATA. Consequently, in addition to literature and database investigation, the OECD opened a call for relevant assays in 2018 to receive suggestions. Here, we report on the definition of NGTxC, on the development of the overarching NGTxC IATA, and on the development of ranking parameters to evaluate the assays. Ultimately the intent is to select the best scoring assays for integration in an NGTxC IATA to better identify carcinogens and reduce public health hazards. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00204-020-02784-5) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2020-06-27 2020 /pmc/articles/PMC7395040/ /pubmed/32594184 http://dx.doi.org/10.1007/s00204-020-02784-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Meeting Reports
Jacobs, Miriam N.
Colacci, Annamaria
Corvi, Raffaella
Vaccari, Monica
Aguila, M. Cecilia
Corvaro, Marco
Delrue, Nathalie
Desaulniers, Daniel
Ertych, Norman
Jacobs, Abigail
Luijten, Mirjam
Madia, Federica
Nishikawa, Akiyoshi
Ogawa, Kumiko
Ohmori, Kiyomi
Paparella, Martin
Sharma, Anoop Kumar
Vasseur, Paule
Chemical carcinogen safety testing: OECD expert group international consensus on the development of an integrated approach for the testing and assessment of chemical non-genotoxic carcinogens
title Chemical carcinogen safety testing: OECD expert group international consensus on the development of an integrated approach for the testing and assessment of chemical non-genotoxic carcinogens
title_full Chemical carcinogen safety testing: OECD expert group international consensus on the development of an integrated approach for the testing and assessment of chemical non-genotoxic carcinogens
title_fullStr Chemical carcinogen safety testing: OECD expert group international consensus on the development of an integrated approach for the testing and assessment of chemical non-genotoxic carcinogens
title_full_unstemmed Chemical carcinogen safety testing: OECD expert group international consensus on the development of an integrated approach for the testing and assessment of chemical non-genotoxic carcinogens
title_short Chemical carcinogen safety testing: OECD expert group international consensus on the development of an integrated approach for the testing and assessment of chemical non-genotoxic carcinogens
title_sort chemical carcinogen safety testing: oecd expert group international consensus on the development of an integrated approach for the testing and assessment of chemical non-genotoxic carcinogens
topic Meeting Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395040/
https://www.ncbi.nlm.nih.gov/pubmed/32594184
http://dx.doi.org/10.1007/s00204-020-02784-5
work_keys_str_mv AT jacobsmiriamn chemicalcarcinogensafetytestingoecdexpertgroupinternationalconsensusonthedevelopmentofanintegratedapproachforthetestingandassessmentofchemicalnongenotoxiccarcinogens
AT colacciannamaria chemicalcarcinogensafetytestingoecdexpertgroupinternationalconsensusonthedevelopmentofanintegratedapproachforthetestingandassessmentofchemicalnongenotoxiccarcinogens
AT corviraffaella chemicalcarcinogensafetytestingoecdexpertgroupinternationalconsensusonthedevelopmentofanintegratedapproachforthetestingandassessmentofchemicalnongenotoxiccarcinogens
AT vaccarimonica chemicalcarcinogensafetytestingoecdexpertgroupinternationalconsensusonthedevelopmentofanintegratedapproachforthetestingandassessmentofchemicalnongenotoxiccarcinogens
AT aguilamcecilia chemicalcarcinogensafetytestingoecdexpertgroupinternationalconsensusonthedevelopmentofanintegratedapproachforthetestingandassessmentofchemicalnongenotoxiccarcinogens
AT corvaromarco chemicalcarcinogensafetytestingoecdexpertgroupinternationalconsensusonthedevelopmentofanintegratedapproachforthetestingandassessmentofchemicalnongenotoxiccarcinogens
AT delruenathalie chemicalcarcinogensafetytestingoecdexpertgroupinternationalconsensusonthedevelopmentofanintegratedapproachforthetestingandassessmentofchemicalnongenotoxiccarcinogens
AT desaulniersdaniel chemicalcarcinogensafetytestingoecdexpertgroupinternationalconsensusonthedevelopmentofanintegratedapproachforthetestingandassessmentofchemicalnongenotoxiccarcinogens
AT ertychnorman chemicalcarcinogensafetytestingoecdexpertgroupinternationalconsensusonthedevelopmentofanintegratedapproachforthetestingandassessmentofchemicalnongenotoxiccarcinogens
AT jacobsabigail chemicalcarcinogensafetytestingoecdexpertgroupinternationalconsensusonthedevelopmentofanintegratedapproachforthetestingandassessmentofchemicalnongenotoxiccarcinogens
AT luijtenmirjam chemicalcarcinogensafetytestingoecdexpertgroupinternationalconsensusonthedevelopmentofanintegratedapproachforthetestingandassessmentofchemicalnongenotoxiccarcinogens
AT madiafederica chemicalcarcinogensafetytestingoecdexpertgroupinternationalconsensusonthedevelopmentofanintegratedapproachforthetestingandassessmentofchemicalnongenotoxiccarcinogens
AT nishikawaakiyoshi chemicalcarcinogensafetytestingoecdexpertgroupinternationalconsensusonthedevelopmentofanintegratedapproachforthetestingandassessmentofchemicalnongenotoxiccarcinogens
AT ogawakumiko chemicalcarcinogensafetytestingoecdexpertgroupinternationalconsensusonthedevelopmentofanintegratedapproachforthetestingandassessmentofchemicalnongenotoxiccarcinogens
AT ohmorikiyomi chemicalcarcinogensafetytestingoecdexpertgroupinternationalconsensusonthedevelopmentofanintegratedapproachforthetestingandassessmentofchemicalnongenotoxiccarcinogens
AT paparellamartin chemicalcarcinogensafetytestingoecdexpertgroupinternationalconsensusonthedevelopmentofanintegratedapproachforthetestingandassessmentofchemicalnongenotoxiccarcinogens
AT sharmaanoopkumar chemicalcarcinogensafetytestingoecdexpertgroupinternationalconsensusonthedevelopmentofanintegratedapproachforthetestingandassessmentofchemicalnongenotoxiccarcinogens
AT vasseurpaule chemicalcarcinogensafetytestingoecdexpertgroupinternationalconsensusonthedevelopmentofanintegratedapproachforthetestingandassessmentofchemicalnongenotoxiccarcinogens